Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
Completed · Phase 3 · Has a placebo group
Conditions studied: Postmenopausal Symptoms
In brief
The purpose of this study is to assess the safety \& efficacy of Brisdelle (paroxetine mesylate) Capsules 7.5 mg for treatment of vasomotor symptoms (VMS) associated with menopause.
Key facts
- Study ID
- NCT01361308
- Run by
- Noven Therapeutics
- People needed
- 614
- Starts
- 2011-05-01
- Expected to finish
- 2012-02-01
- Last updated by the study team
- 2015-10-15
Who can join
Age: 40 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female, ≥ 40 years of age at screening (inclusive)
- Reported more than 7-8 moderate to severe hot flashes per day (average) or 50-60 moderate to severe hot flashes per week for at least 30 days prior to the screening visit
- Spontaneous amenorrhea for at least 12 consecutive months or
- Amenorrhea for at least 6 months and meet the biochemical criteria for menopause or
- Bilateral salpingo-oophorectomy ≥ 6 weeks with or without hysterectomy
You may not qualify if…
- Known non-responder to previous Selective serotonin reuptake inhibitor (SSRI) or Serotonin norepinephrine reuptake inhibitor (SNRI) treatment for VMS
- History of self injurious behavior
- History of clinical diagnosis of depression or treatment for depression
- History of clinical diagnosis of borderline personality disorder
- Use of an investigational study medication within 30 days prior to screening or during the study
- Concurrent participation in another clinical trial or previous participation in this trial
- Family of investigational-site staff
Where it is running
- East Valley Family Physicians PLC — Chandler, Arizona, United States
- Advanced Research Associates — Glendale, Arizona, United States
- Premier Research Group Limited — Peoria, Arizona, United States
- Verona Clinical Research, Inc — Tucson, Arizona, United States
- NEA Baptist Women's Clinic — Jonesboro, Arkansas, United States
- Grossmont Center for Clinical Research — La Mesa, California, United States
- High Desert Medical Group — Lancaster, California, United States
- Facey Medical Foundation — Mission Hills, California, United States
- Northern California Research — Sacramento, California, United States
- University Clinical Research — San Diego, California, United States
- Medical Center for Clinical Research — San Diego, California, United States
- Apex Research Institute — Santa Ana, California, United States
- Downtown Women's Health Care — Denver, Colorado, United States
- Horizons Clinical Research Center, LLC — Denver, Colorado, United States
- The Women's Clinic of Northern Colorado — Fort Collins, Colorado, United States
- Danbury Clinical Research, LLC — Danbury, Connecticut, United States
- Coastal Connecticut Research, LLC — New London, Connecticut, United States
- James A. Simon, MD, PC — Washington D.C., District of Columbia, United States
- Meridien Research — Bradenton, Florida, United States
- Meridien Research — Brooksville, Florida, United States
- Tampa Bay Medical Research, Inc. — Clearwater, Florida, United States
- DBC Research — Deerfield Beach, Florida, United States
- Clinical Physiology Associates — Fort Myers, Florida, United States
- University of Florida College of Medicine - Jacksonville Southside Women's Health — Jacksonville, Florida, United States
- Wilmax Clinical Research — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.